Multiple-to-multiple relationships between microRNAs and target genes in gastric cancer

Yutaka Hashimoto1, Yoshimitsu Akiyama, Yasuhito Yuasa

  • 1Department of Molecular Oncology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.

Plos One
|May 14, 2013
PubMed

Insights

Combinations of microRNAs (miRNAs) can synergistically regulate multiple target genes, impacting gastric cancer development. These miRNA groups, often silenced by promoter hypermethylation, reveal complex, multiple-to-multiple regulatory networks in cancer.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • MicroRNAs (miRNAs) are key transcriptional regulators implicated in carcinogenesis.
  • Existing research often describes simplified miRNA-target interactions (one-to-one, one-to-multiple, or multiple-to-one).
  • The complex, multiple-to-multiple regulatory roles of miRNA combinations in gastric cancer (GC) remain underexplored.

Purpose of the Study:

  • To investigate synergistic regulatory roles of miRNA combinations in human gastric cancer.
  • To identify specific miRNA groups and their common target genes involved in gastric carcinogenesis.
  • To elucidate the regulatory mechanisms, including promoter hypermethylation, affecting these miRNAs in GC.

Main Methods:

  • Re-analysis of miRNA expression array data from a GC cell line treated with 5-aza-2 -deoxycytidine.
  • Utilizing the TargetScan database to predict common target genes for up-regulated miRNAs.
  • Cross-referencing with the GEO database for target gene expression in human GCs.
  • Transfection experiments to assess the functional impact of miRNA combinations on target gene expression and cell proliferation.
  • Analysis of miRNA promoter methylation status in GC cells.

Main Results:

  • Two miRNA combinations, (miR-224 and -452) and (miR-181c and -340), were identified.
  • These combinations synergistically down-regulated their predicted common target genes: DPYSL2 and KRAS for the first pair, and KRAS and MECP2 for the second.
  • Transfection with these miRNA combinations led to a significant decrease in cancer cell proliferation.
  • The studied miRNAs were found to be down-regulated in GC cells due to promoter hypermethylation.

Conclusions:

  • MiRNA-target interactions in gastric cancer are complex, exhibiting multiple-to-multiple relationships.
  • Synergistic actions of miRNA combinations play a significant role in regulating target genes critical for gastric carcinogenesis.
  • Epigenetic silencing via promoter hypermethylation contributes to the dysregulation of these tumor-suppressive miRNAs in GC.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...